In rare cases, GLP-1 agonists may cause serious side effects, including allergic reactions, pancreatitis, gallbladder disease, and kidney disease.[ref][ref] Obviously, talk with your doctor about the risks vs
The packaging of some of these products carries the logos of state therapeutic products agencies, such as Swissmedic (Switzerland), the FDA (USA) or BfArM (Germany), as well as other imaginary certifications
This included Matthias Tschp (figure 39), a German who completed a medical degree at Ludwig Maximilian University of Munich in 1993 and then worked as a clinician in neuroendocrinology before taking up a research fellowship at Eli Lilly Discovery Research Laboratories in 1999 to gain expertise in drug discovery and development
To maintain weight loss, lifestyle changes must be sustained even after stopping Semaglutide GLP-1 treatment